Updates

Ref: Akums/Exchange/2026-27/26 June 19, 2026 To, To, The Listing Department The Listing Department National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, C-1, Block G, 25th Floor, New Trading Ring, Bandra Kurla Complex, Rotunda Building, Phiroze Jeejeebhoy Bandra (E), Mumbai – 400 051 Towers, Dalal Street, Mumbai – 400 001 Symbol: AKUMS Scrip Code: 544222 Sub: Notice and Integrated Annual Report for the Financial Year 2025-26 to those members who have not registered their e-mail ID’s Respected Sir/Ma’am, Pursuant to Regulation 36(1)(b) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Akums Drugs and Pharmaceuticals Limited (“the Company”) has sent a letter providing the web-link, including the exact path, where the Integrated Annual Report of the Company for the Financial Year 2025-26 is available, to those members who have not registered their e-mail ID’s with the Company/ MUFG Intime India Private Limited (formerly known as Link Intime India Private Limited) - Registrar and Transfer Agent Depositories (“RTA”)/ Depository Participants (“DPs”). A copy of the letter is enclosed herewith as “Annexure – A” This is for your information and records. Thanking you, For Akums Drugs and Pharmaceuticals Limited Dharamvir Malik Company Secretary & Compliance Officer Encl.: As above Annexure-A AKUMS DRUGS AND PHARMACEUTICALS LIMITED CIN: L24239DL2004PLC125888 Regd. Office: 304, 3rd Floor, Mohan Place, L.S.C., Block – C, Saraswati Vihar, New Delhi - 110034, Delhi, India Corporate Office: Akums House, Plot No. 131 to 133, Block-C, Mangolpuri Ind. Area, Phase-1, Delhi - 110083 Tel: +91-11-69001000, Fax: +91-11-27023256, E-mail: akumsho@akums.net Website: www.akums.in Notice of the 22nd Annual General Meeting and Integrated Annual Report for the Financial Year 2025-26 We are pleased to inform you that the 22nd Annual General Meeting (“AGM”) of Akums Drugs and Pharmaceuticals Limited (“the Company”) will be held on Friday, July 10, 2026 at 11:00 A.M. (IST) through Video Conferencing (“VC”)/ Other Audio-Visual Means (“OAVM”) in accordance with the applicable circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India. In compliance with the Regulation 36(1)(a) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), electronic copies of the Notice of the 22nd AGM with the weblinks of the websites where the Integrated Annual Report for the Financial Year 2025-26 is available, were sent to all the members whose email id’s are registered with the Company / MUFG Intime India Private Limited - Registrar and Transfer Agent Depositories (“RTA”)/ Depository Participants via e-mail on Thursday, June 18, 2026. As per the records available with the Company and/or its RTA, your e-mail id is not registered against the Demat Account/Folio No. and therefore, in accordance with Regulation 36(1)(b) of the Listing Regulations, we are sending you this letter to inform that the Notice of the 22nd AGM and Integrated Annual Report for the Financial Year 2025–26, can be accessed through the following links or paths: Particulars Web-link and Exact Path, where Annual Report is available Company’s https://www.akums.in/investors/annual-report/ website www.akums.in >> Financials and Reports >> Notice and Annual Report >> FY 2025-2026 >> Integrated Annual Report 2025-26 BSE https://www.bseindia.com/xml-data/corpfiling/attachlive/40c769ef-bb37-46e6-a96d-e95b55734c3a.pdf Limited (“BSE”) www.bseindia.com >> Please enter Security Name/ Code/ ID/ ISIN i.e. Akums Drugs and Pharmaceuticals Ltd/ AKUMS / 544222 / INE09XN01023 >> Financials >> Annual Reports >> Annual Report of the Year 2026 National https://nsearchives.nseindia.com/annual_reports/AR_29407_AKUMS_2025_2026_A_12534185_18062026174836.pdf Stock Exchange of India Ltd. www.nseindia.com >> Please search by Company name or Symbol i.e. Akums Drugs and Pharmaceuticals Limited or (“NSE”) Akums >> Annual Reports >> Click on the Annual Report for the period starting From Year: 2025 To Year: 2026 National https://www.evoting.nsdl.com/eVotingWeb/downloadAction.do?fileType=resolutionFile Securities Depository Limited www.evoting.nsdl.com/ >> Notice Download >> Please select Akums Drugs and Pharmaceuticals Limited and download (“NSDL”) the file We request you to access the Integrated Annual Report of the Company for the Financial Year 2025-26 from the aforesaid weblinks or paths. We hereby request the members of the Company to register their e-mail Id’s and update their PAN, Aadhaar, Bank and other details, if any, in the Demat Accounts through their Depository Participants for receiving the communications from the Company and timely credit of dividend in their Bank Account(s). For Akums Drugs and Pharmaceuticals Limited Sd/- Dharamvir Malik Company Secretary and Compliance Officer Date:18.06.2026 Place: Delhi